What is the appropriate oral treatment for a urinary tract infection caused by Staphylococcus lugdunensis?

Oral Treatment for Staphylococcus lugdunensis UTI

For a urinary tract infection caused by Staphylococcus lugdunensis, treat with trimethoprim-sulfamethoxazole (TMP-SMX) 160/800 mg twice daily for 7 days as first-line therapy, or alternatively use a fluoroquinolone (ciprofloxacin 500 mg twice daily for 7 days) if TMP-SMX cannot be used.

Rationale and Evidence

Why S. lugdunensis UTIs Require Special Consideration

S. lugdunensis is an unusual coagulase-negative staphylococcus that behaves more like S. aureus than typical coagulase-negative staphylococci, with significantly higher virulence 1. While UTIs represent approximately 10% of S. lugdunensis infections 2, 3, this organism requires species-level identification because of its aggressive behavior and distinct treatment requirements 4.

Antimicrobial Susceptibility Profile

Recent large-scale surveillance data demonstrates that S. lugdunensis maintains excellent susceptibility to multiple oral agents:

• TMP-SMX: 95.9-100% susceptible 5, 6, 7, 3
• Fluoroquinolones: 95.9% susceptible 5, 3
• Oxacillin: 84.1% susceptible (though 16% resistance noted) 6, 3
• Vancomycin: 100% susceptible 5, 6, 7

Notably, penicillin resistance varies widely (15-87% globally) 6, making beta-lactams less reliable as empiric therapy.

Treatment Algorithm

Step 1: Confirm diagnosis

• Urine culture with ≥10⁵ CFU/mL
• Species-level identification (requires MALDI-TOF MS or specialized biochemical testing) 1, 4

Step 2: Assess severity

• Uncomplicated cystitis: Oral therapy for 7 days
• Pyelonephritis or systemic symptoms: Consider initial IV therapy then transition to oral

Step 3: Select antibiotic based on susceptibilities

First-line (if susceptible):

• TMP-SMX 160/800 mg (1 double-strength tablet) twice daily × 7 days 8, 9

Alternative options (if TMP-SMX contraindicated or resistant):

• Ciprofloxacin 500 mg twice daily × 7 days 10
• Levofloxacin 750 mg once daily × 5 days 10

For oxacillin-susceptible strains:

• Cephalexin 500 mg four times daily × 7 days (though less data for S. lugdunensis specifically) 11

Critical Pitfalls to Avoid

1. Do not treat as typical coagulase-negative staphylococcus: S. lugdunensis requires the same treatment duration and intensity as S. aureus infections 1, 4

2. Do not use nitrofurantoin or fosfomycin: While these are first-line agents for typical uncomplicated cystitis caused by E. coli 12, 9, there is insufficient data supporting their efficacy against staphylococcal UTIs

3. Ensure adequate treatment duration: Use 7 days minimum for cystitis (not the 3-5 day courses used for gram-negative UTIs) 8

4. Watch for complications: S. lugdunensis can cause abscess formation and invasive disease; if symptoms persist beyond 48-72 hours, obtain imaging to rule out perinephric abscess or other complications 2, 4

Special Populations

If methicillin-resistant (rare but reported):

• Vancomycin IV initially, then transition to oral TMP-SMX or fluoroquinolone based on susceptibilities 5
• SCCmec type V is most common among resistant strains 5

Pregnancy considerations:

• Avoid TMP-SMX in first and third trimesters 12
• Avoid fluoroquinolones throughout pregnancy
• Consider cephalexin if susceptible, or consult infectious disease

Post-Treatment Follow-Up

Routine post-treatment urine cultures are not indicated if symptoms resolve 12. However, if symptoms persist or recur within 2 weeks, repeat culture with susceptibility testing is mandatory 12.